320 related articles for article (PubMed ID: 16687238)
1. Bisphosphonate-induced avascular osteonecrosis of the jaws: a clinical report of 11 cases.
Dimitrakopoulos I; Magopoulos C; Karakasis D
Int J Oral Maxillofac Surg; 2006 Jul; 35(7):588-93. PubMed ID: 16687238
[TBL] [Abstract][Full Text] [Related]
2. Osteonecrosis of the jaws due to bisphosphonate use. A review of 60 cases and treatment proposals.
Magopoulos C; Karakinaris G; Telioudis Z; Vahtsevanos K; Dimitrakopoulos I; Antoniadis K; Delaroudis S
Am J Otolaryngol; 2007; 28(3):158-63. PubMed ID: 17499130
[TBL] [Abstract][Full Text] [Related]
3. Bisphosphonate-associated osteonecrosis of the jaws: a therapeutic dilemma.
Diego R; D'Orto O; Pagani D; Agazzi A; Marzano U; Derada Troletti G; Fontanella W; Pignataro L
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Mar; 103(3):e1-5. PubMed ID: 17197204
[TBL] [Abstract][Full Text] [Related]
4. Bisphosphonate-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment.
Marx RE; Sawatari Y; Fortin M; Broumand V
J Oral Maxillofac Surg; 2005 Nov; 63(11):1567-75. PubMed ID: 16243172
[TBL] [Abstract][Full Text] [Related]
5. Treating low- and medium-potency bisphosphonate-related osteonecrosis of the jaws with a protocol for the treatment of chronic suppurative osteomyelitis: report of 7 cases.
Alons K; Kuijpers SC; de Jong E; van Merkesteyn JP
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 Feb; 107(2):e1-7. PubMed ID: 19071040
[TBL] [Abstract][Full Text] [Related]
6. The role of surgical resection in the management of bisphosphonate-related osteonecrosis of the jaws.
Carlson ER; Basile JD
J Oral Maxillofac Surg; 2009 May; 67(5 Suppl):85-95. PubMed ID: 19371819
[TBL] [Abstract][Full Text] [Related]
7. Bisphosphonate-associated osteonecrosis of mandibular and maxillary bone: an emerging oral complication of supportive cancer therapy.
Migliorati CA; Schubert MM; Peterson DE; Seneda LM
Cancer; 2005 Jul; 104(1):83-93. PubMed ID: 15929121
[TBL] [Abstract][Full Text] [Related]
8. Jaw bone necrosis without previous dental extractions associated with the use of bisphosphonates (pamidronate and zoledronate): a four-case report.
Merigo E; Manfredi M; Meleti M; Corradi D; Vescovi P
J Oral Pathol Med; 2005 Nov; 34(10):613-7. PubMed ID: 16202082
[TBL] [Abstract][Full Text] [Related]
9. Avascular mandibular osteonecrosis in association with bisphosphonate therapy: a report on four patients.
Friedrich RE; Blake FA
Anticancer Res; 2007; 27(4A):1841-5. PubMed ID: 17649782
[TBL] [Abstract][Full Text] [Related]
10. Osteonecrosis of the jaw associated with bisphosphonate use: Presentation of seven cases and literature review.
Mortensen M; Lawson W; Montazem A
Laryngoscope; 2007 Jan; 117(1):30-4. PubMed ID: 17202926
[TBL] [Abstract][Full Text] [Related]
11. Osteonecrosis of the jaws and bisphosphonates. Report of three cases.
Pastor-Zuazaga D; Garatea-Crelgo J; Martino-Gorbea R; Etayo-Pérez A; Sebastián-López C
Med Oral Patol Oral Cir Bucal; 2006 Jan; 11(1):E76-9. PubMed ID: 16388300
[TBL] [Abstract][Full Text] [Related]
12. Consequence of therapy discontinuation in bisphosphonate-associated osteonecrosis of the jaws.
Gallego L; Junquera L
Br J Oral Maxillofac Surg; 2009 Jan; 47(1):67-8. PubMed ID: 18639371
[TBL] [Abstract][Full Text] [Related]
13. Osteonecrosis of the jaws in patients treated with bisphosphonates - histomorphologic analysis in comparison with infected osteoradionecrosis.
Hansen T; Kunkel M; Weber A; James Kirkpatrick C
J Oral Pathol Med; 2006 Mar; 35(3):155-60. PubMed ID: 16454811
[TBL] [Abstract][Full Text] [Related]
14. Prevalence and risk factors of bisphosphonate-associated osteonecrosis of the jaw in prostate cancer patients with advanced disease treated with zoledronate.
Walter C; Al-Nawas B; Grötz KA; Thomas C; Thüroff JW; Zinser V; Gamm H; Beck J; Wagner W
Eur Urol; 2008 Nov; 54(5):1066-72. PubMed ID: 18602738
[TBL] [Abstract][Full Text] [Related]
15. Osteonecrosis of the maxilla in a patient with a history of bisphosphonate therapy.
Melo MD; Obeid G
J Can Dent Assoc; 2005 Feb; 71(2):111-3. PubMed ID: 15691429
[TBL] [Abstract][Full Text] [Related]
16. Osteonecrosis of the jaws in periodontal patients with a history of bisphosphonates treatment.
Ficarra G; Beninati F; Rubino I; Vannucchi A; Longo G; Tonelli P; Pini Prato G
J Clin Periodontol; 2005 Nov; 32(11):1123-8. PubMed ID: 16212571
[TBL] [Abstract][Full Text] [Related]
17. "Bis-phossy jaws" - high and low risk factors for bisphosphonate-induced osteonecrosis of the jaw.
Abu-Id MH; Warnke PH; Gottschalk J; Springer I; Wiltfang J; Acil Y; Russo PA; Kreusch T
J Craniomaxillofac Surg; 2008 Mar; 36(2):95-103. PubMed ID: 18234504
[TBL] [Abstract][Full Text] [Related]
18. Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: incidence and risk factors.
Bamias A; Kastritis E; Bamia C; Moulopoulos LA; Melakopoulos I; Bozas G; Koutsoukou V; Gika D; Anagnostopoulos A; Papadimitriou C; Terpos E; Dimopoulos MA
J Clin Oncol; 2005 Dec; 23(34):8580-7. PubMed ID: 16314620
[TBL] [Abstract][Full Text] [Related]
19. Osteonecrosis of the jaw as an adverse bisphosphonate event: three cases of bone metastatic prostate cancer patients treated with zoledronic acid.
García Sáenz JA; López Tarruella S; García Paredes B; Rodríguez Lajusticia L; Villalobos L; Díaz Rubio E
Med Oral Patol Oral Cir Bucal; 2007 Sep; 12(5):E351-6. PubMed ID: 17767097
[TBL] [Abstract][Full Text] [Related]
20. Maxilla osseus sequestre and oral exposure: effects of the treatment of multiple myeloma with bisphosphonates.
Lobato JV; Rodrigues JM; Cavaleiro MV; Lobato JM; Xavier L; Santos JD; Maurício AC
Acta Med Port; 2007; 20(2):185-92. PubMed ID: 17868526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
